person · Reporting owner

Roush John A

Disclosed activity across 4 companies

Tapewire entity: 1928
SEC CIK: 0001308225

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
ADVANCED ENERGY INDUSTRIES INCAEIS · Entity 3497	Director	May 07, 2026	May 08, 2026
LEMAITRE VASCULAR INCLMAT · Entity 1927	Director	September 03, 2026	September 08, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

ADVANCED ENERGY INDUSTRIES INC

Report date May 07, 2026 · Filed May 08, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	587	Reported balance After 2026-05-07 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2026-05-07 · Grant · Acquired 587 · Balance 587 F1: Represents an annual grant of restricted stock units to the reporting person on May 7, 2026 as the equity portion of the non-employee directors' retainer for Board services under the 2023 Amended and Restated Omnibus Incentive Plan. The restricted stock units vest on the one-year anniversary of the grant date contingent upon the reporting person's continued service as director upon such date. F2: Restricted stock units are not exercisable and do not have an expiration date.

Filing footnotes · ownership attribution and instrument terms

F1: Represents an annual grant of restricted stock units to the reporting person on May 7, 2026 as the equity portion of the non-employee directors' retainer for Board services under the 2023 Amended and Restated Omnibus Incentive Plan. The restricted stock units vest on the one-year anniversary of the grant date contingent upon the reporting person's continued service as director upon such date.

F2: Restricted stock units are not exercisable and do not have an expiration date.

LEMAITRE VASCULAR INC

Report date September 03, 2026 · Filed September 08, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Dividend Equivalent RightsSEC Table II · derivative / convertible security	Direct	5.6103	Reported balance After 2026-09-03 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2026-09-03 · Grant · Acquired 0.5429 · Balance 5.6103 F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
Dividend Equivalent RightsSEC Table II · derivative / convertible security	Direct	5.5195	Reported balance After 2026-09-03 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2026-09-03 · Grant · Acquired 0.6503 · Balance 5.5195 F2: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
Dividend Equivalent RightsSEC Table II · derivative / convertible security	Direct	5.1836	Reported balance After 2026-09-03 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2026-09-03 · Grant · Acquired 0.8852 · Balance 5.1836 F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
Dividend Equivalent RightsSEC Table II · derivative / convertible security	Direct	5.486	Reported balance After 2026-09-03 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2026-09-03 · Grant · Acquired 1.0022 · Balance 5.486 F4: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
Dividend Equivalent RightsSEC Table II · derivative / convertible security	Direct	4.2988	Reported balance After 2026-09-03 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2026-09-03 · Grant · Acquired 1.6637 · Balance 4.2988 F5: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Filing footnotes · ownership attribution and instrument terms

F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F2: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F5: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

ESS Tech, Inc.

Report date October 08, 2021 · Filed October 13, 2021

Section 16 reporting ended · disclosed 2021-10-13. Current position is not established by this disclosure.

No balance rows disclosed in this filing.

NOVANTA INC

Report date September 01, 2016 · Filed September 06, 2016

Section 16 reporting ended · disclosed 2016-09-06. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	477,961	Ending reported balance After 2016-09-01 transaction · row 6 6 source rows · reconciled sequence Row 1 · 2016-09-01 · Exercise / conversion · Acquired 15,310 · Balance 473,899 Row 2 · 2016-09-01 · Tax withholding · Disposed 7,204 · Balance 466,695 Row 3 · 2016-09-01 · Exercise / conversion · Acquired 15,186 · Balance 481,881 Row 4 · 2016-09-01 · Tax withholding · Disposed 7,146 · Balance 474,735 Row 5 · 2016-09-01 · Exercise / conversion · Acquired 6,094 · Balance 480,829 Row 6 · 2016-09-01 · Tax withholding · Disposed 2,868 · Balance 477,961
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2016-09-01 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2016-09-01 · Exercise / conversion · Disposed 15,310 · Balance 0 F1: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share upon vesting of such Restricted Stock Unit. F2: Represents the pro-rata vesting of the Reporting Person's outstanding Restricted Stock Units in accordance with the terms of the Transition and Release of Claims Agreement dated July 27, 2016. The Reporting Person's unvested Restricted Stock Units have been forfeited.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2016-09-01 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2016-09-01 · Exercise / conversion · Disposed 15,186 · Balance 0 F1: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share upon vesting of such Restricted Stock Unit. F2: Represents the pro-rata vesting of the Reporting Person's outstanding Restricted Stock Units in accordance with the terms of the Transition and Release of Claims Agreement dated July 27, 2016. The Reporting Person's unvested Restricted Stock Units have been forfeited.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2016-09-01 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2016-09-01 · Exercise / conversion · Disposed 6,094 · Balance 0 F1: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share upon vesting of such Restricted Stock Unit. F2: Represents the pro-rata vesting of the Reporting Person's outstanding Restricted Stock Units in accordance with the terms of the Transition and Release of Claims Agreement dated July 27, 2016. The Reporting Person's unvested Restricted Stock Units have been forfeited.

Filing footnotes · ownership attribution and instrument terms

F1: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share upon vesting of such Restricted Stock Unit.

F2: Represents the pro-rata vesting of the Reporting Person's outstanding Restricted Stock Units in accordance with the terms of the Transition and Release of Claims Agreement dated July 27, 2016. The Reporting Person's unvested Restricted Stock Units have been forfeited.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
September 04, 2025 Filed Sep 8, 2025 22:31 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantDividend Equivalent Rights · Derivative	0.4173	$0.00	$0.00	Disclosure SEC source: 0001437749-25-028587 · rdgdoc.xml · derivative · entry 2 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5.5269 Underlying: Common Stock · 0.4173 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
September 04, 2025 Filed Sep 8, 2025 22:31 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantDividend Equivalent Rights · Derivative	0.4173	$0.00	$0.00	Disclosure SEC source: 0001437749-25-028587 · rdgdoc.xml · derivative · entry 1 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6.5156 Underlying: Common Stock · 0.4173 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
August 11, 2025 Filed Aug 13, 2025 12:54 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	Exercise / conversionStock Option (Right to Buy) · Derivative	6,561	$0.00 Strike: $37.29	$0.00	Disclosure SEC source: 0001437749-25-026364 · rdgdoc.xml · derivative · entry 7 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,561 shares Expires 2025-12-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document
August 11, 2025 Filed Aug 13, 2025 12:54 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	SaleCommon Stock	1,574	$91.82	$144,521.69	Disclosure SEC source: 0001437749-25-026364 · rdgdoc.xml · nonDerivative · entry 5 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,916 F4 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $91.38 to $92.14. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document
August 11, 2025 Filed Aug 13, 2025 12:54 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	SaleCommon Stock	4,987	$92.78	$462,708.82	Disclosure SEC source: 0001437749-25-026364 · rdgdoc.xml · nonDerivative · entry 4 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,490 F3 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $92.21 to $93.20. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document
August 11, 2025 Filed Aug 13, 2025 12:54 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	Exercise / conversionCommon Stock	6,561	$37.29	$244,659.69	Disclosure SEC source: 0001437749-25-026364 · rdgdoc.xml · nonDerivative · entry 3 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,477 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document
August 08, 2025 Filed Aug 13, 2025 12:54 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	Exercise / conversionStock Option (Right to Buy) · Derivative	939	$0.00 Strike: $37.29	$0.00	Disclosure SEC source: 0001437749-25-026364 · rdgdoc.xml · derivative · entry 6 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,561 Underlying: Common Stock · 939 shares Expires 2025-12-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document
August 08, 2025 Filed Aug 13, 2025 12:54 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	SaleCommon Stock	939	$93.49	$87,784.48	Disclosure SEC source: 0001437749-25-026364 · rdgdoc.xml · nonDerivative · entry 2 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,916 F2 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $93.025 to $94.00. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document
August 08, 2025 Filed Aug 13, 2025 12:54 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	Exercise / conversionCommon Stock	939	$37.29	$35,015.31	Disclosure SEC source: 0001437749-25-026364 · rdgdoc.xml · nonDerivative · entry 1 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,855 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document
May 29, 2025 Filed Jun 2, 2025 20:27 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantDividend Equivalent Rights · Derivative	1.0387	$0.00	$0.00	Disclosure SEC source: 0001437749-25-019169 · rdgdoc.xml · derivative · entry 5 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2.0397 Underlying: Common Stock · 1.0387 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
May 29, 2025 Filed Jun 2, 2025 20:27 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantDividend Equivalent Rights · Derivative	1.0208	$0.00	$0.00	Disclosure SEC source: 0001437749-25-019169 · rdgdoc.xml · derivative · entry 4 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5.0145 Underlying: Common Stock · 1.0208 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
May 29, 2025 Filed Jun 2, 2025 20:27 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantDividend Equivalent Rights · Derivative	0.8524	$0.00	$0.00	Disclosure SEC source: 0001437749-25-019169 · rdgdoc.xml · derivative · entry 3 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4.6837 Underlying: Common Stock · 0.8524 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
May 29, 2025 Filed Jun 2, 2025 20:27 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantDividend Equivalent Rights · Derivative	0.4985	$0.00	$0.00	Disclosure SEC source: 0001437749-25-019169 · rdgdoc.xml · derivative · entry 2 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5.1096 Underlying: Common Stock · 0.4985 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
May 29, 2025 Filed Jun 2, 2025 20:27 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantDividend Equivalent Rights · Derivative	0.4985	$0.00	$0.00	Disclosure SEC source: 0001437749-25-019169 · rdgdoc.xml · derivative · entry 1 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6.0983 Underlying: Common Stock · 0.4985 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
May 03, 2025 Filed May 6, 2025 23:22 UTC	ADVANCED ENERGY INDUSTRIES INC AEIS · Entity 3497	Exercise / conversionRestricted Stock Units · Derivative	2,093	$0.00	$0.00	Disclosure SEC source: 0000950170-25-064785 · ownership.xml · derivative · entry 3 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,093 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On May 3, 2024, the reporting person was granted 2,093 restricted stock units, which vested on the one-year anniversary of the grant date. Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: Restricted stock units are not exercisable and do not have an expiration date. F3 · derivative.expiration_date: Restricted stock units are not exercisable and do not have an expiration date. Read SEC document
May 03, 2025 Filed May 6, 2025 23:22 UTC	ADVANCED ENERGY INDUSTRIES INC AEIS · Entity 3497	Exercise / conversionCommon Stock	2,093	Not disclosed	Not disclosed	Disclosure SEC source: 0000950170-25-064785 · ownership.xml · nonDerivative · entry 1 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,818 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On May 3, 2024, the reporting person was granted 2,093 restricted stock units, which vested on the one-year anniversary of the grant date. Restricted stock units convert into common stock on a one-for-one basis. Read SEC document
May 02, 2025 Filed May 6, 2025 23:22 UTC	ADVANCED ENERGY INDUSTRIES INC AEIS · Entity 3497	GrantRestricted Stock Units · Derivative	2,313	$0.00	$0.00	Disclosure SEC source: 0000950170-25-064785 · ownership.xml · derivative · entry 2 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,313 Underlying: Common Stock · 2,313 shares Expires not disclosed F2 · derivative.exercise_price: Represents an annual grant of restricted stock units to the reporting person on May 2, 2025 as the equity portion of the non-employee directors' retainer for Board services under the 2023 Amended and Restated Omnibus Incentive Plan. The restricted stock units vest on the one-year anniversary of the grant date contingent upon the reporting person's continued service as director upon such date. F3 · derivative.exercise_date: Restricted stock units are not exercisable and do not have an expiration date. F3 · derivative.expiration_date: Restricted stock units are not exercisable and do not have an expiration date. Read SEC document
March 27, 2025 Filed Mar 31, 2025 21:32 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantDividend Equivalent Rights · Derivative	1.001	$0.00	$0.00	Disclosure SEC source: 0001437749-25-010300 · rdgdoc.xml · derivative · entry 5 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1.001 Underlying: Common Stock · 1.001 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
March 27, 2025 Filed Mar 31, 2025 21:32 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantDividend Equivalent Rights · Derivative	0.9838	$0.00	$0.00	Disclosure SEC source: 0001437749-25-010300 · rdgdoc.xml · derivative · entry 4 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3.9937 Underlying: Common Stock · 0.9838 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
March 27, 2025 Filed Mar 31, 2025 21:32 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantDividend Equivalent Rights · Derivative	0.8214	$0.00	$0.00	Disclosure SEC source: 0001437749-25-010300 · rdgdoc.xml · derivative · entry 3 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3.8313 Underlying: Common Stock · 0.8214 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
March 27, 2025 Filed Mar 31, 2025 21:32 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantDividend Equivalent Rights · Derivative	0.4803	$0.00	$0.00	Disclosure SEC source: 0001437749-25-010300 · rdgdoc.xml · derivative · entry 2 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4.6111 Underlying: Common Stock · 0.4803 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
March 27, 2025 Filed Mar 31, 2025 21:32 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantDividend Equivalent Rights · Derivative	0.4803	$0.00	$0.00	Disclosure SEC source: 0001437749-25-010300 · rdgdoc.xml · derivative · entry 1 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5.5998 Underlying: Common Stock · 0.4803 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
February 28, 2025 Filed Mar 5, 2025 00:30 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	Exercise / conversionDividend Equivalent Rights · Derivative	1	$0.00	$0.00	Disclosure SEC source: 0001437749-25-006162 · rdgdoc.xml · derivative · entry 3 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3.0099 Underlying: Common Stock · 1 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a performance share unit (PSU) award granted on December 8, 2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · shares: These dividend equivalent rights were released in connection with the vesting of a performance share unit (PSU) award granted on December 8, 2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a performance share unit (PSU) award granted on December 8, 2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a performance share unit (PSU) award granted on December 8, 2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
February 28, 2025 Filed Mar 5, 2025 00:30 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	Exercise / conversionCommon Stock	1	$0.00	$0.00	Disclosure SEC source: 0001437749-25-006162 · rdgdoc.xml · nonDerivative · entry 2 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,916 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document
February 28, 2025 Filed Mar 5, 2025 00:30 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantCommon Stock	204	$0.00	$0.00	Disclosure SEC source: 0001437749-25-006162 · rdgdoc.xml · nonDerivative · entry 1 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,915 F1 · shares: These shares represent LMAT common stock acquired on February 28, 2025, upon settlement of a Performance Share Unit (PSU) award granted on December 8, 2023. The PSU award vests as follows: 1/3 upon determination by the Compensation Committee and the balance vests in equal annual installments from the grant date over the next two years. F2 · price: Each PSU represents a contingent right to receive one share of common stock upon vesting based on the attainment of performance goals. Read SEC document
December 12, 2024 Filed Dec 13, 2024 22:56 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	Exercise / conversionDividend Equivalent Rights · Derivative	3	$0.00	$0.00	Disclosure SEC source: 0001437749-24-037499 · rdgdoc.xml · derivative · entry 6 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4.1308 Underlying: Common Stock · 3 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a performance stock unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · shares: These dividend equivalent rights were released in connection with the vesting of a performance stock unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a performance stock unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a performance stock unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
December 12, 2024 Filed Dec 13, 2024 22:56 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	Exercise / conversionDividend Equivalent Rights · Derivative	3	$0.00	$0.00	Disclosure SEC source: 0001437749-24-037499 · rdgdoc.xml · derivative · entry 5 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5.1195 Underlying: Common Stock · 3 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
December 12, 2024 Filed Dec 13, 2024 22:56 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	Exercise / conversionCommon Stock	3	$0.00	$0.00	Disclosure SEC source: 0001437749-24-037499 · rdgdoc.xml · nonDerivative · entry 3 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,711 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document
December 12, 2024 Filed Dec 13, 2024 22:56 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	Exercise / conversionCommon Stock	3	$0.00	$0.00	Disclosure SEC source: 0001437749-24-037499 · rdgdoc.xml · nonDerivative · entry 2 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,708 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document
December 11, 2024 Filed Dec 13, 2024 22:56 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	Exercise / conversionDividend Equivalent Rights · Derivative	6	$0.00	$0.00	Disclosure SEC source: 0001437749-24-037499 · rdgdoc.xml · derivative · entry 4 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1.9846 Underlying: Common Stock · 6 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 11, 2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 11, 2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 11, 2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 11, 2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
December 11, 2024 Filed Dec 13, 2024 22:56 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	Exercise / conversionCommon Stock	6	$0.00	$0.00	Disclosure SEC source: 0001437749-24-037499 · rdgdoc.xml · nonDerivative · entry 1 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,705 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document
December 09, 2024 Filed Dec 12, 2024 02:24 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	Exercise / conversionDividend Equivalent Rights · Derivative	1	$0.00	$0.00	Disclosure SEC source: 0001437749-24-037275 · rdgdoc.xml · derivative · entry 2 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3.0099 Underlying: Common Stock · 1 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 8, 2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 8, 2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 8, 2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 8, 2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
December 09, 2024 Filed Dec 12, 2024 02:24 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	Exercise / conversionCommon Stock	1	$0.00	$0.00	Disclosure SEC source: 0001437749-24-037275 · rdgdoc.xml · nonDerivative · entry 1 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,699 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document
December 06, 2024 Filed Dec 10, 2024 22:37 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantStock Option (Right to Buy) · Derivative	2,594	$0.00 Strike: $101.12	$0.00	Disclosure SEC source: 0001437749-24-037141 · rdgdoc.xml · derivative · entry 3 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,594 Underlying: Common Stock · 2,594 shares Expires 2029-12-06 F2 · derivative.exercise_date: This option is exercisable and vests over a three-year period at a rate of 33 1/3% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining two years. Read SEC document
December 06, 2024 Filed Dec 10, 2024 22:37 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantCommon Stock	420	$0.00	$0.00	Disclosure SEC source: 0001437749-24-037141 · rdgdoc.xml · nonDerivative · entry 1 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,698 F1 · shares: Represents a restricted stock unit award that vests on a time-based schedule as follows: 33 1/3% of the award vests on the anniversary of the grant date listed in the table, with the balance vesting in equal annual installments over the remaining two years. Read SEC document
December 05, 2024 Filed Dec 10, 2024 00:16 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantDividend Equivalent Rights · Derivative	0.8043	$0.00	$0.00	Disclosure SEC source: 0001437749-24-037041 · rdgdoc.xml · derivative · entry 4 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4.0099 Underlying: Common Stock · 0.8043 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
December 05, 2024 Filed Dec 10, 2024 00:16 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantDividend Equivalent Rights · Derivative	0.6284	$0.00	$0.00	Disclosure SEC source: 0001437749-24-037041 · rdgdoc.xml · derivative · entry 3 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7.1308 Underlying: Common Stock · 0.6284 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
December 05, 2024 Filed Dec 10, 2024 00:16 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantDividend Equivalent Rights · Derivative	0.6284	$0.00	$0.00	Disclosure SEC source: 0001437749-24-037041 · rdgdoc.xml · derivative · entry 2 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8.1195 Underlying: Common Stock · 0.6284 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
December 05, 2024 Filed Dec 10, 2024 00:16 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantDividend Equivalent Rights · Derivative	0.3103	$0.00	$0.00	Disclosure SEC source: 0001437749-24-037041 · rdgdoc.xml · derivative · entry 1 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7.9846 Underlying: Common Stock · 0.3103 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
August 29, 2024 Filed Sep 4, 2024 00:03 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantDividend Equivalent Rights · Derivative	0.9285	$0.00	$0.00	Disclosure SEC source: 0001437749-24-028312 · rdgdoc.xml · derivative · entry 4 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3.2056 Underlying: Common Stock · 0.9285 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
August 29, 2024 Filed Sep 4, 2024 00:03 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantDividend Equivalent Rights · Derivative	0.7254	$0.00	$0.00	Disclosure SEC source: 0001437749-24-028312 · rdgdoc.xml · derivative · entry 3 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6.5024 Underlying: Common Stock · 0.7254 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
August 29, 2024 Filed Sep 4, 2024 00:03 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantDividend Equivalent Rights · Derivative	0.7254	$0.00	$0.00	Disclosure SEC source: 0001437749-24-028312 · rdgdoc.xml · derivative · entry 2 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7.4911 Underlying: Common Stock · 0.7254 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
August 29, 2024 Filed Sep 4, 2024 00:03 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantDividend Equivalent Rights · Derivative	0.358	$0.00	$0.00	Disclosure SEC source: 0001437749-24-028312 · rdgdoc.xml · derivative · entry 1 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7.6743 Underlying: Common Stock · 0.358 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
May 30, 2024 Filed Jun 3, 2024 21:27 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantDividend Equivalent Rights · Derivative	1.0426	$0.00	$0.00	Disclosure SEC source: 0001437749-24-019078 · rdgdoc.xml · derivative · entry 4 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2.2771 Underlying: Common Stock · 1.0426 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
May 30, 2024 Filed Jun 3, 2024 21:27 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantDividend Equivalent Rights · Derivative	0.8146	$0.00	$0.00	Disclosure SEC source: 0001437749-24-019078 · rdgdoc.xml · derivative · entry 3 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5.777 Underlying: Common Stock · 0.8146 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
May 30, 2024 Filed Jun 3, 2024 21:27 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantDividend Equivalent Rights · Derivative	0.8146	$0.00	$0.00	Disclosure SEC source: 0001437749-24-019078 · rdgdoc.xml · derivative · entry 2 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6.7657 Underlying: Common Stock · 0.8146 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
May 30, 2024 Filed Jun 3, 2024 21:27 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantDividend Equivalent Rights · Derivative	0.402	$0.00	$0.00	Disclosure SEC source: 0001437749-24-019078 · rdgdoc.xml · derivative · entry 1 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7.3163 Underlying: Common Stock · 0.402 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
May 05, 2024 Filed May 7, 2024 23:30 UTC	ADVANCED ENERGY INDUSTRIES INC AEIS · Entity 3497	Exercise / conversionRestricted Stock Units · Derivative	2,257	$0.00	$0.00	Disclosure SEC source: 0000950170-24-054929 · ownership.xml · derivative · entry 3 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,257 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On May 5, 2023, the reporting person was granted 2,257 restricted stock units, which vested on the one-year anniversary of the grant date. Restricted stock units convert into common stock on a one-for-one basis. F1 · derivative.exercise_date: On May 5, 2023, the reporting person was granted 2,257 restricted stock units, which vested on the one-year anniversary of the grant date. Restricted stock units convert into common stock on a one-for-one basis. F1 · derivative.expiration_date: On May 5, 2023, the reporting person was granted 2,257 restricted stock units, which vested on the one-year anniversary of the grant date. Restricted stock units convert into common stock on a one-for-one basis. Read SEC document
May 05, 2024 Filed May 7, 2024 23:30 UTC	ADVANCED ENERGY INDUSTRIES INC AEIS · Entity 3497	Exercise / conversionCommon Stock	2,257	Not disclosed	Not disclosed	Disclosure SEC source: 0000950170-24-054929 · ownership.xml · nonDerivative · entry 1 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,725 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On May 5, 2023, the reporting person was granted 2,257 restricted stock units, which vested on the one-year anniversary of the grant date. Restricted stock units convert into common stock on a one-for-one basis. Read SEC document
May 03, 2024 Filed May 7, 2024 23:30 UTC	ADVANCED ENERGY INDUSTRIES INC AEIS · Entity 3497	GrantRestricted Stock Units · Derivative	2,093	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000950170-24-054929 · ownership.xml · derivative · entry 2 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,093 Underlying: Common Stock · 2,093 shares Expires not disclosed F2 · kind: Represents an annual grant of restricted stock units to the reporting person on May 3, 2024 as the equity portion of the non-employee directors' retainer for Board services under the 2023 Amended and Restated Omnibus Incentive Plan. The restricted stock units vest on the one-year anniversary of the grant date contingent upon the reporting person's continued service as director upon such date. F3 · derivative.exercise_date: Restricted stock units are not exercisable and do not have an expiration date. F3 · derivative.expiration_date: Restricted stock units are not exercisable and do not have an expiration date. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.